FRT-P-C vs RXRX

Comparison between Federal Realty Investment Trust. (FRT-P-C, Company) and Recursion Pharmaceuticals Inc - Class A (RXRX, Company).

5-Year PerformanceFRT-P-C has outperformed RXRX, delivering a return of -0.0% compared to -38.8%

FRT-P-C vs RXRX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	FRT-P-C(COMPANY)	RXRX(COMPANY)
Market Cap	$1.76B	$1.76B
Max Drawdown	30.45%	93.13%
Sharpe Ratio	-0.13	-0.61
5Y Beta	0.23	2.63
Industry	Other	Biotechnology
P/E Ratio	4.28	-2.87
PEG Ratio	0.12	N/A
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	22.55%	-10.03%
Debt to Equity	152.79%	0.00%
Free Cash Flow Yield	35.40%	-18.55%
P/S Ratio	N/A	26.45
P/B Ratio	N/A	1.73

Market Cap

Winner

FRT-P-C

$1.76B

RXRX

$1.76B

Max Drawdown

Winner

FRT-P-C

30.45%

RXRX

93.13%

Sharpe Ratio

Winner

FRT-P-C

-0.13

RXRX

-0.61

5Y Beta

Winner

FRT-P-C

0.23

RXRX

2.63

Industry

FRT-P-C

Other

RXRX

Biotechnology

P/E Ratio

FRT-P-C

4.28

Winner

RXRX

-2.87

PEG Ratio

FRT-P-C

0.12

RXRX

N/A

5Y Dividends CAGR

FRT-P-C

4.56%

RXRX

N/A

5Y EPS CAGR

Winner

FRT-P-C

22.55%

RXRX

-10.03%

Debt to Equity

FRT-P-C

152.79%

Winner

RXRX

0.00%

Free Cash Flow Yield

Winner

FRT-P-C

35.40%

RXRX

-18.55%

P/S Ratio

FRT-P-C

N/A

RXRX

26.45

P/B Ratio

FRT-P-C

N/A

RXRX

1.73

FRT-P-C vs RXRX - Historical Returns

Returns include dividend reinvestment.

Period	FRT-P-C	RXRX
1 month	-0.17%	-3.14%
3 months	+2.50%	-13.48%
6 months	-0.07%	-33.19%
1 year	+2.06%	-51.88%
5 years(CAGR)	-0.03%	-38.84%
10 years(CAGR)	+2.61%	N/A
Max(CAGR)	+2.61%	-35.64%

Winner

FRT-P-C

-0.17%

RXRX

-3.14%

Winner

FRT-P-C

+2.50%

RXRX

-13.48%

Winner

FRT-P-C

-0.07%

RXRX

-33.19%

Winner

FRT-P-C

+2.06%

RXRX

-51.88%

5Y(CAGR)

Winner

FRT-P-C

-0.03%

RXRX

-38.84%

10Y(CAGR)

FRT-P-C

+2.61%

RXRX

N/A

Max(CAGR)

Winner

FRT-P-C

+2.61%

RXRX

-35.64%

FRT-P-C vs RXRX - Annual Returns (2017 - 2026)

Returns include dividend reinvestment.

Year	FRT-P-C	RXRX
2026	+0.63%	-26.67%
2025	-2.16%	-43.27%
2024	-1.76%	-31.51%
2023	+16.50%	+30.60%
2022	-16.34%	-57.24%
2021	+3.95%	-45.27%
2020	+4.48%	N/A
2019	+28.40%	N/A
2018	-11.86%	N/A
2017	+1.93%	N/A

FRT-P-C vs RXRX Drawdown Comparison

The maximum drawdown for FRT-P-C was -28.33%, occurring on Mar 23, 2020. Recovery took 121 trading sessions.

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current FRT-P-C drawdown is -6.69%. The current RXRX drawdown is -92.55%.

Rank	FRT-P-C	RXRX
#1	-28.33% Feb 18, 2020 - Aug 10, 2020	-93.13% Jul 13, 2021 - Mar 30, 2026
#2	-24.15% Aug 3, 2022 - Jan 30, 2024	-38.10% Apr 29, 2021 - Jun 17, 2021
#3	-15.21% Jun 18, 2018 - Feb 5, 2019	-10.54% Apr 16, 2021 - Apr 21, 2021
#4	-13.81% Dec 29, 2017 - Jun 18, 2018	-10.45% Jun 21, 2021 - Jul 6, 2021
#5	-12.96% Oct 18, 2024 - Apr 7, 2025	-8.29% Apr 21, 2021 - Apr 29, 2021
#6	-12.59% Jan 30, 2024 - Sep 20, 2024	N/A
#7	-10.87% Jul 7, 2021 - Jul 29, 2022	N/A
#8	-6.00% Oct 7, 2020 - Apr 1, 2021	N/A
#9	-5.25% Feb 6, 2019 - Apr 3, 2019	N/A
#10	-3.67% Oct 23, 2019 - Jan 2, 2020	N/A
#11	-3.54% Apr 13, 2021 - Jul 7, 2021	N/A
#12	-2.80% Sep 26, 2017 - Dec 15, 2017	N/A
#13	-2.54% Aug 18, 2020 - Sep 15, 2020	N/A
#14	-2.32% Sep 22, 2020 - Sep 28, 2020	N/A
#15	-1.96% Sep 4, 2019 - Oct 11, 2019	N/A